Molecular Mechanisms of Anti-Inflammatory Action of Erythromycin in Human Bronchial Epithelial Cells: Possible Role in the Signaling Pathway That Regulates Nuclear Factor-κB Activation

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 5, 2004, Pages 1581-1585

  Desaki, Masashi ^a   Okazaki, Hitoshi ^a   Sunazuka, Toshiaki ^b   Omura, Satoshi ^b   Yamamoto, Kazuhiko ^a   Takizawa, Hajime ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Kitasato Kenkyusho Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EM 703; ERYTHROMYCIN; ERYTHROMYCIN DERIVATIVE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MACROLIDE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRONCHUS MUCOSA; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; EPITHELIUM CELL; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN TARGETING; REGULATORY MECHANISM; WESTERN BLOTTING;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; BRONCHIOLITIS; CELLS, CULTURED; CYTOKINES; DNA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EPITHELIAL CELLS; ERYTHROMYCIN; HUMANS; INTERLEUKIN-8; NF-KAPPA B; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2142700049     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.5.1581-1585.2004     Document Type: Article

References (23)

1. Barthelemy, P., D. Autissier, G. Gerbaud, and P. Courvalin. 1984. Enzymic hydrolysis of erythromycin by a strain of Escherichia coli: a new mechanism of resistance. J. Antibiot. 37:1692-1696.
2. 2-terminal kinase-mediated redox-dependent degradation of IκB: role of thioredoxin in NF-κB activation. J. Biol. Chem. 276:4662-4670.
3. Desaki, M., I. Sugawara, Y. Iwakura, K. Yamamoto, and H. Takizawa. 2002. Role of interferon-γ in the development of murine bronchus-associated lymphoid tissues induced by silica in vivo. Toxicol. Appl. Pharmacol. 185:1-7.
4. Desaki, M., H. Takizawa, T. Kasama, K. Kobayashi, Y. Morita, and K. Yamamoto. 2000. Nuclear factor-κB activation in silica-induced interleukin 8 production by human bronchial epithelial cells. Cytokine 12:1257-1260.
5. Desaki, M., H. Takizawa, T. Ohtoshi, T. Kasama, K. Kobayashi, T. Sunazuka, S. Omura, K. Yamamoto, and K. Ito. 2000. Erythromycin suppresses nuclear factor-κB and activator protein-1 activation in human bronchial epithelial cells. Biochem. Biophys. Res. Commun. 267:124-128.
6. Galter, D., S. MIHM, and W. Droge. 1994. Distinct effects of glutathione disulphide on the nuclear transcription factors κB and the activator protein-1. Eur. J. Biochem. 221:639-648.
7. Hayashi, T., Y. Ueno, and T. Okamoto. 1993. Oxidoreductive regulation of nuclear factor κB. J. Biol. Chem. 268:11380-11388.
8. Homma, H., A. Yamanaka, S. Tanimoto, M. Tamura, Y. Chijimatsu, S. Kira, and T. Izumi. 1983. Diffuse panbronchiolitis. A disease of the transitional zone of the lung. Chest 83:63-69.
9. Kadota, J., O. Sakito, S. Kohno, H. Sawa, H. Mukae, H. Oda, K. Kawakami, K. Fukushima, K. Hiratani, and K. Hara. 1993. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am. Rev. Respir. Dis. 147:153-159.
10. Lentsch, A. B., B. J. Czermak, N. M. Bless, and P. A. Ward. 1998. NF-κB activation during IgG immune complex-induced lung injury: requirements for TNF-α and IL-1β but not complement. Am. J. Pathol. 152:1327-1336.
11. Mukaida, N., S. Okamoto, Y. Ishikawa, and K. Matsushima. 1994. Molecular mechanism of interleukin-8 gene expression. J. Leukoc. Biol. 56:554-558.
12. Okazaki, H., J. Zhang, M. M. Hamawy, and R. P. Siraganian. 1997. Activation of protein-tyrosine kinase Pyk2 is downstream of Syk in FcεRI signaling. J. Biol. Chem. 272:32443-32447.
13. Omura, S., K. Tsuzuki, T. Sunazuka, S. Marui, H. Toyoda, N. Inatomi, and Z. Itoh. 1987. Macrolides with gastrointestinal motor stimulating activity. J. Med. Chem. 30:1941-1943.
14. Rubin, B. K., H. Druce, O. E. Ramirez, and R. Palmer. 1997. Effect of clarithromycin on nasal mucus properties in healthy subjects and in patients with purulent rhinitis. Am. J. Respir. Crit. Care Med. 155:2018-2023.
15. Rubin, B. K., and J. Tamaoki. 2000. Macrolide antibiotics as biological response modifiers. Curr. Opin. Investig. Drugs 1:169-172.
16. Sato, K., M. Suga, T. Akaike, S. Fujii, H. Muranaka, T. Doi, H. Maeda, and M. Ando. 1998. Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice. Am. J. Respir. Crit. Care Med. 157:853-857.
17. Sun, Y., and L. W. Oberley. 1996. Redox regulation of transcriptional activators. Free Radic. Biol. Med. 21:335-348.
18. Takizawa, H., M. Desaki, T. Ohtoshi, S. Kawasaki, T. Kohyama, M. Sato, J. Nakajima, M. Yanagisawa, and K. Ito. 1998. Erythromycin and clarithromycin attenuate cytokine-induced endothelin-1 expression in human bronchial epithelial cells. Eur. Respir. J. 12:57-63.
19. Takizawa, H., M. Desaki, T. Ohtoshi, S. Kawasaki, T. Kohyama, M. Sato, M. Tanaka, T. Kasama, K. Kobayashi, J. Nakajima, and K. Ito. 1997. Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells. Am. J. Respir. Crit. Care Med. 156:266-271.
20. Takizawa, H., M. Desaki, T. Ohtoshi, T. Kikutani, H. Okazaki, M. Sato, N. Akiyama, S. Shoji, K. Hiramatsu, and K. Ito. 1995. Erythromycin suppresses interleukin 6 expression by human bronchial epithelial cells. Biochem. Biophys. Res. Commun. 210:781-786.
21. Takizawa, H., T. Ohtoshi, S. Kawasaki, T. Kohyama, M. Desaki, T. Kasama, K. Kobayashi, K. Nakahara, K. Yamamoto, K. Matsushima, and S. Kudoh. 1999. Diesel exhaust particles induce NF-κB activation in human bronchial epithelial cells in vitro: importance in cytokine transcription. J. Immunol. 162:4705-4711.
22. Toledano, M. B., and W. J. Leonard. 1991. Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. USA 88:4328-4332.
23. Umeki, S. 1993. Anti-inflammatory action of erythromycin. Its inhibitory effect on neutrophil NADPH oxidase activity. Chest 104:1191-1193.